SPONSOR
Chong Kun Dang Pharmaceutical
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 4
NCT06954766 Phase 2
Recruiting
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
Knee Osteoarthritis
NCT06431477 Phase 4
Recruiting
Efficacy and Safety of Telmisartan Compared With Losartan
Diabetic Nephropathies
NCT06044493 Phase 4
Recruiting
MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
Kidney Transplant